1999 - E. Mead Johnson Award, Society for Pediatric Research
Steven H. Abman mainly focuses on Pulmonary hypertension, Internal medicine, Lung, Respiratory disease and Endocrinology. Steven H. Abman has researched Pulmonary hypertension in several fields, including Anesthesia, Hypoxia, Circulatory system, Vascular resistance and Pulmonary artery. His biological study spans a wide range of topics, including Gastroenterology, Fetus and Cardiology.
His research integrates issues of Bronchopulmonary dysplasia, Angiogenesis, Vascular endothelial growth factor and Pathology in his study of Lung. The Respiratory disease study combines topics in areas such as Adverse effect, Hypoxemia and Intensive care medicine. Steven H. Abman interconnects Vascular endothelial growth factor A and Hypoalbuminemia in the investigation of issues within Endocrinology.
Steven H. Abman mostly deals with Internal medicine, Pulmonary hypertension, Lung, Cardiology and Bronchopulmonary dysplasia. The concepts of his Internal medicine study are interwoven with issues in Fetus and Endocrinology. The study incorporates disciplines such as Respiratory disease, Intensive care medicine, Vascular disease, Heart disease and Vasodilation in addition to Pulmonary hypertension.
The various areas that Steven H. Abman examines in his Lung study include Angiogenesis, Vascular endothelial growth factor, Hypoxia and Pathology. His work carried out in the field of Cardiology brings together such families of science as Congenital diaphragmatic hernia and Surgery. His Nitric oxide research integrates issues from Oxygenation and Anesthesia.
His primary areas of investigation include Pulmonary hypertension, Bronchopulmonary dysplasia, Internal medicine, Lung and Cardiology. His Pulmonary hypertension study also includes
Intensive care medicine that connect with fields like MEDLINE,
Hemodynamics that intertwine with fields like Magnetic resonance imaging. His Bronchopulmonary dysplasia study also includes fields such as
Pediatrics together with Respiratory disease, Retrospective cohort study, Incidence and Respiratory system,
Preeclampsia which is related to area like Obstetrics.
His work deals with themes such as Gastroenterology and Endocrinology, which intersect with Internal medicine. Steven H. Abman combines subjects such as Congenital diaphragmatic hernia, Pathophysiology, Pathology and Alveolar capillary dysplasia with his study of Lung. In his work, Bioinformatics is strongly intertwined with Fetus, which is a subfield of Pathology.
His main research concerns Pulmonary hypertension, Bronchopulmonary dysplasia, Lung, Internal medicine and Pediatrics. His Pulmonary hypertension research includes elements of Congenital diaphragmatic hernia, Fetus, Pathophysiology and Disease. His Bronchopulmonary dysplasia research integrates issues from Birth weight, Postmenstrual Age, Vascular disease and Intensive care medicine.
He combines subjects such as Alveolar capillary dysplasia, Persistent Fetal Circulation Syndrome, Airway and Pathology with his study of Lung. His Internal medicine research is multidisciplinary, incorporating elements of Tube formation, Endocrinology and Cardiology. He has researched Pediatrics in several fields, including Respiratory disease, Incidence and Respiratory failure.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Fetal and Neonatal Physiology
Richard A. Polin;William W. Fox;Steven H. Abman.
Inhibition of VEGF receptors causes lung cell apoptosis and emphysema
Yasunori Kasahara;Rubin M. Tuder;Laimute Taraseviciene-Stewart;Timothy D. Le Cras.
Journal of Clinical Investigation (2000)
Prostacyclin Synthase Expression Is Decreased in Lungs from Patients with Severe Pulmonary Hypertension
Rubin M. Tuder;Carlyne D. Cool;Mark W. Geraci;Jun Wang.
American Journal of Respiratory and Critical Care Medicine (1999)
Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn
J. P. Kinsella;S. R. Neish;E. Shaffer;S. H. Abman.
The Lancet (1992)
Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.
Vallerie V. McLaughlin;Kenneth W. Presberg;Ramona L. Doyle;Steven H. Abman.
Inhibition of angiogenesis decreases alveolarization in the developing rat lung.
Malathi Jakkula;Timothy D. Le Cras;Sarah Gebb;K. Peter Hirth.
American Journal of Physiology-lung Cellular and Molecular Physiology (2000)
Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease.
Bernard Thébaud;Steven H. Abman.
American Journal of Respiratory and Critical Care Medicine (2007)
Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society
Steven H. Abman;Georg Hansmann;Stephen L. Archer;D. Dunbar Ivy.
Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn
John P. Kinsella;William E. Truog;William F. Walsh;Ronald N. Goldberg.
The Journal of Pediatrics (1997)
Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth.
S. H. Abman;B. A. Chatfield;S. L. Hall;I. F. McMurtry.
American Journal of Physiology-heart and Circulatory Physiology (1990)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: